Ankylosing spondylitis trials, also abroad
89 open Ankylosing spondylitis trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment has 1 site in Denmark and runs in 10 countries. If a site near you is full, another one may still take people.
See An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment in all 10 countries